While we now have access to adequate computing power for most applications, we lack the tools required to properly manage the investigative process. We need the tools to organize the results of the numerous model configurations, sort through the results and compare alternative formations of the model in order to determine reasonable next steps and decide that a particular model or group of models is adequate for the task at hand. And this is where the idea of “workflow” comes to the forefront.

KIWI has been specifically designed to recognize the dynamic nature of the model building effort in an ongoing drug development program. KIWI provides functionality to meet the scientists’ need for extensive documentation of the analysis pathway and collateral results, management’s need for summaries of modeling and simulation highlights, and regulatory agencies need for transparency and reproducibility.